Deflux is indicated for treatment of children with vesicoureteral reflux (VUR) grades II-IV.

Patients should not receive DEFLUX (hyaluronic acid/dextranomer) if they have any of the following conditions: kidneys that don’t work (non-functional kidney[s]), bulging or herniation in the skin of the bladder (hutch diverticulum), swelling at the bottom of the ureter (ureterocele), a disorder in eliminating urine (active voiding dysfunction), and ongoing urinary tract infection.

Safety and efficacy of treatment in children under 1 year of age have not been established.

Safety and efficacy of treatment of duplex kidney systems have not been established.

If your child has VUR,
we're here to help

Deflux® is indicated for treatment of children
with vesicoureteral reflux (VUR) grades II-IV.

Patients should not receive DEFLUX (hyaluronic acid/dextranomer) if they have any of the following conditions: kidneys that don’t work (non-functional kidney[s]), bulging or herniation in the skin of the bladder (hutch diverticulum), swelling at the bottom of the ureter (ureterocele), a disorder in eliminating urine (active voiding dysfunction), and ongoing urinary tract infection.

Safety and efficacy of treatment in children under 1 year of age have not been established.

Safety and efficacy of treatment of duplex kidney systems have not been established.

VUR in Children

A diagnosis of vesicoureteral reflux (VUR), sometimes called bladder or urinary reflux, may appear scary, but it doesn’t have to be. It’s actually a condition that affects 1% of US children.1   Continue >

About Deflux

If you’re a concerned parent, ask your pediatric urologist about Deflux. Deflux is a minimally invasive procedure that has been proven effective in treating children with VUR.2

Patients should not receive Deflux if they have any of the following conditions: kidneys that don't work (non-functional kidney[s]), bulging or herniation in the skin of the bladder (hutch diverticulum), swelling at the bottom of the ureter (ureterocele), a disorder in eliminating urine (active voiding dysfunction), and ongoing urinary tract infection.   Continue >

Indication for DEFLUX

Deflux® is indicated for treatment of children with vesicoureteral reflux (VUR) grades II-IV.

Important Safety Information about DEFLUX

Patients should not receive DEFLUX® (hyaluronic acid/dextranomer) if they have any of the following conditions: kidneys that don't work (non-functional kidney[s]), bulging or herniation in the skin of the bladder (hutch diverticulum), swelling at the bottom of the ureter (ureterocele), a disorder in eliminating urine (active voiding dysfunction), and ongoing urinary tract infection.

Patients who are known to be allergic to hyaluronic-acid based products or dextran should not receive DEFLUX.

Safety and efficacy of treatment in children under 1 year of age have not been established.

Safety and efficacy of treatment of duplex kidney systems have not been established.

There is a risk of infection and bleeding that is associated with the cystoscopic procedure used to inject DEFLUX.

Talk to your doctor if your child has ureters with grossly dilated orifices before receiving DEFLUX treatment.

DEFLUX should only be administered by qualified surgeons experienced performing urological procedures.

In clinical studies the most common side effects associated with DEFLUX were: urinary tract infection (UTI), ureteral dilation, and nausea/vomiting/abdominal pain.

The following adverse events have been reported with Deflux : blockage of the ureters (some cases require temporary placement of a ureteric stent), painful urination, blood in the urine, urgency of urination, frequency of urination, swelling of the kidneys, inflammation of the kidneys, urinary tract infection, foreign body reaction, calcification, and fever.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch/ or call 1-800-FDA-1088.

For product information, adverse event reports, and product complaint reports, please contact:

Salix Product Information Call Center
Phone: 1-800-508-0024
Fax: 1-510-595-8183
Email: salix@medcomsol.com

Please see complete Prescribing Information for DEFLUX.Deflux Vesicoureteral Reflux Prescribing Information (PI)